Us > Scientific
We rely on and give thanks to our scientific
advisors who provide feedback on the content we provide on
lymphomation.org. Their guidance is essential -- helping PAL to
goal of providing evidence- and science-based information for
caregivers and patients with lymphoma.
Michael R. Bishop, MD | Dr.
Maurizio Bendandi , MD, PhD
Densmore, MD, PhD | Jeff P. Sharman, MD
Lynda Olender, R.N.
A.N.P., C.N.A.A | Alberto-Mussetti, MD
Olender, MD | Dimitris
Placantonakis, MD, PhD
Queimado, MD, PhD | Dr.
Croaker, MD | Allen Cohen, MD
Dr. Michael Bishop
Director, Hematopoietic Cellular
Section of Hematology/Oncology
University of Chicago
Michael R. Bishop, MD
Dr. Bishop received his M.D. from the University of Illinois in 1985. He
completed clinical training in internal medicine at Northwestern
University in 1988 and a fellowship in hematology and oncology at Loyola
University Medical Center in 1991. He was an assistant professor of
medicine at the University of Kentucky Medical Center from 1991 to 1992
and an associate professor of medicine at the University of Nebraska
Medical Center from 1992 to 1999, where he served as director of the
Leukemia and Allogeneic Stem Cell Transplantation Programs.
Dr. Bishop joined the National Cancer Institute in March 1999 to serve
as the Clinical Head of the Stem Cell Transplantation Program. In 2003,
he received the National Institutes of Health Distinguished Clinical
Teacher Award. He received tenure as Senior Investigator at NIH in 2007.
In 2009 he organized and co-chaired the First International Workshop on
the Biology, Prevention, and Treatment of Relapse after Allogeneic
Hematopoietic Cell Transplantation. In 2011 Dr. Bishop's was appointed
as Head of the Hematologic Malignancies Section in the Division of
Hematology and Oncology at the Medical College of Wisconsin/Froedtert
Hospital in Milwaukee. In 2012, Dr. Bishop was recruited to serve as the
director of the University of Chicago Hematopoietic Stem Cell
Transplantation Program and was appointed Professor of Medicine in the
Division of Hematology and Oncology, Department of Medicine at the
University of Chicago. In 2013, Dr. Bishop was named a Bucksbaum
Institute for Clinical Excellence Master Clinician.
Dr. Bishop’s research focuses on the development and conduct novel
clinical trials in hematopoietic stem cell transplantation. Particular
areas of interest include the therapeutic use of T cells to accentuate
graft-versus-tumor effects. In addition, his research program is focuses
on methods to prevent and treat recurrent disease following allogeneic
stem cell transplantation, with primary focus on non-Hodgkin lymphomas.
Dr. Bishop has authored or co-authored over 150 peer-reviewed articles
and over 20 book chapters relative to the fields of hematologic
malignancies and hematopoietic stem cell transplantation. He serves as a
reviewer and on the editorial boards of numerous scientific journals
including Journal of Clinical Oncology, Blood, Biology of Blood and
Marrow Transplantation, and Experimental Biology and Medicine.
Dr. Maurizio Bendandi, MD, PhD
Maurizio Bendandi , MD, PhD
"... Dr. Bendandi has been a pioneer in the field of cancer
vaccines, developing his vision towards the achievement of
proofs-of-principle, not only as an academician, but also in
collaboration with the pharmaceutical industry.
Updated CV pending
Jeff Sharman, M.D.
University of California, Davis
Dr. Sharman's CLL
and Lymphoma Blog
Jeff P. Sharman, MD
Dr Sharman enjoys practicing in a
rapidly developing field that can offer new
hope to patients.
"I enjoy taking care of
patients facing difficult, frightening
medical conditions such as cancer," he says.
"Advances in medical oncology are occurring
because of our rapidly expanding
understanding of the causes of cancer."
At Stanford, his research into new drugs
for lymphoma gained international attention
and received unique recognition from the
American Society of Hematology.
Dr. Sharman is a member of the US
Oncology Hematologic Malignancies Research
Committee and has an active roll in clinical
trial development for WVCI. He has a
particular interest in the care of patients
with cancers of the blood and lymphatic
system. He enjoys using personalized
medicine -- determining unique molecular
characteristics of the patients and their
cancers to provide the most effective
treatments with the fewest toxicities.
Dr. Sharman's interests include cycling,
waterskiing, hiking, international travel,
scuba diving and jazz.
John Densmore, MD, PhD
Densmore, MD, PhD
Dr. Densmore is Assistant Professor of Clinical Internal Medicine at the University of Virginia. He is interested in biologic approaches to the treatment of lymphoma and is participating in clinical trials of idiotype vaccines and other immunotherapy approaches to the treatment of lymphoma.
R.N., A.N.P., C.N.A.A.
Lynda Olender, R.N.
is serving as Chief Nurse Executive, Bronx VA Medical Center. In this role she plans, develops, directs and evaluates nursing practices across all Patient Care Centers within the medical center. Additionally she serves as a consultant in Clinical Nutrition having served on an interdisciplinary Nutrition Support Team for over 10 years. In this role she advises care for high nutritional risk patients - many receiving feeding by feeding tube or via the intravenous route. She is also an Assistant Professor, Division of Nursing - New York University, and has developed curriculum and instructed for both undergraduate and graduate courses including Professional Nursing, Leadership in Nursing, Comparative Health Systems (for Nurses and Allied Health students) for the last 12 years.
Alberto Mussetti, MD
Dr. Mussetti is a graduate of the School of Medicine, Università Statale degli Studi di
Milano, Milan – Italy, Magna cum laude
Postdoctoral Training includes:
• March 2010 - May 2010: resident physician, Department of Pediatric
Oncology, IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori,
Milan – Italy, 2010
• June 2010 - November 2010: resident physician, Internal Medicine VI°
Dpt, IRCCS Ospedale San Paolo, Milan – Italy
• December 2010 – June 2013: Resident in Hematology, Division of
Hematology and Bone Marrow Transplantation, IRCCS Istituto Nazionale per
lo Studio e la Cura dei Tumori, Milan – Italy
• September 2011:Voluntary physician, Pediatric Ward, St.Kizito Matany
Karamoja – Uganda
• July 2013 - present: Clinical Research fellow at Adult Stem Cell
Transplant Service, Memorial Sloan Kettering Cancer Center, New York
City – US
Susan Olender, M.D.
Dr. Olender is a graduate of NYU School of
Medicine. Her interests include access to health care and epidemiology.
While at NYU, Susan helped form the first student-operated free clinic
-- the NYC Free Clinic -- sponsored by the School of Medicine, and
co-sponsored by the Institute for Urban Family Health.
Susan also conducted epidemiology research in a developing nation and was a supporting
member of the Physicians for a National Health Care initiative.
Now she is a first year resident in Internal
Medicine-Primary Care at Columbia Presbyterian Medical Center. In
addition access to care, she is interested in pain management of
Dimitris Placantonakis, MD, Ph.D.
Placantonakis, MD, PhD
Dr. Placantonakis is a graduate of NYU School of
Medicine NY. His specialties and areas of expertise include functional neurosurgery, epilepsy,
movement disorders, gene therapy and neuronal tissue imaging.
Lurdes Queimado, MD, PhD
Queimado, MD, PhD
Dr. Queimado is an Assistant Professor of Otorhinolaryngology at The University of Oklahoma Health Sciences Center. Lurdes has a Ph.D. in molecular pathology and
has worked in cancer research since 1992.
Research Interests: My major research interest is in the study of cancer with the ultimate goal of contributing to better prevention, diagnosis, and treatment of cancer. Another area of main interest is DNA repair. Repair of DNA damage is essential for cell survival and mitigates cancer development.
- Further patient’s education. Being well informed is the best tool to fight cancer.
- Increase patient’s participation on clinical trials. Without trials,
better treatments will not be approved.
- Increase funding for basic and clinical research. Without research no novel treatments will be developed.
Susan B. Spector, MS, RD, CDN.
Spector MS, RD, CDN
Susan is Dietetic Internship Director Clinical
Coordinator/Nutrition & Food Program at the U.S. Department of
Andy Croaker, MD
Dr. Croaker has a Bachelor Medicine (Newcastle), FRACGP 2001.
Diagnosed with low grade advanced follicular lymphoma 01/2002 resulting in a
career change. Currently working to form a fund raising organization for
Lymphoma Research and working at the Queensland Institute of Medical Research in the field of immunotherapy.
Allen Cohen, MD
Allen Cohen, MD
Dr. Cohen's bio sketch is pending
... are medical professionals who are
directly fighting NHL while pursuing professional careers. The need to
remain anonymous speaks to the hidden penalties of living with lymphoma in our society.
We especially value the insights and contributions of our
anonymous scientific advisors because they have a unique perspective
based on the
understanding both the
medical system and the experience of living with the disease.
V A, Ph.D. | A
R, MD | H H, MD | DF, Ph.D.